MVP Health Care 2022 Payment Policies (selected sections)
Customize your policy alerts
Sign up for all MVP Health Care policy alerts
Know when MVP Health Care releases new policies or updates existing guidance.
Monitor payer policy activity
This document provides MVP Health Care's reimbursement and billing policies for multiple service areas (e.g., After-Hours, Allergy Testing and Serum Preparation, Evaluation and Management), including coding rules, reimbursement limits, and prior authorization/notification guidance for providers submitting claims to MVP.
No material clinical or coverage changes in this revision.
Coverage Criteria and Clinical Billing Rules
E&M coverage criteria
Covered when ALL of the following are met:
Allergy testing coverage criteria
Covered when ALL of the following are met:
Unit limits
- 95165 (supervision of preparation/provision of antigens): First year limited to 40 units per claim and 160 units per calendar year; subsequent years limited to 30 units per claim and 120 units per calendar year.
- 95004 (percutaneous skin tests): Reimbursement limited to 80 units per calendar year.
- 95028 (intracutaneous delayed reaction tests): Reimbursement limited to 30 units per calendar year.
After-Hours billing criteria
After-hours E/M codes may be billed only under the following conditions:
E&M reimbursement criteria
Reimbursed when ALL applicable rules below are satisfied:
Coverage criteria and billing rules
Provider reimbursement rules, limitations, and billing expectations (applies when listed conditions are met):
Article 28 split billing criteria
Split billing (Article 28) is permitted only when ALL of the following conditions are met:
Audiology coverage and billing rules
Audiology services are covered when the following conditions are met:
Clinical examples (appropriate reasons to order diagnostic testing)
- Evaluation of suspected change in hearing, tinnitus, or balance.
- Evaluation of cause of hearing/tinnitus/balance disorders or effect of medication, surgery, or other treatment.
Vermont audio-only and supervised billing criteria
Vermont-specific audio-only and supervised billing rules apply when ALL applicable conditions are met:
Coverage and exclusion criteria (partial document)
Coverage and exclusions — apply as stated below:
Coverage criteria and exclusions for COVID-19 testing
COVID-19 testing is covered when ALL of the following are satisfied:
Coverage criteria for nutritional counseling and diabetic management
Nutritional counseling and diabetic management are covered when ALL of the following are met:
Reimbursable codes and limits
- Medical nutrition therapy codes 97802–97804 and G0270–G0271 are reimbursable per policy.
- For Medicare MSA plans only, reimbursement for 97802–97804 and G0270–G0271 is limited to specified ICD-10 diagnoses; other plans have no diagnosis restrictions.
Reimbursement criteria and exclusions
Reimbursable diabetic management services and exclusions:
Diagnosis matching and claim denial criteria
Claims for the listed procedures must meet the diagnosis-matching requirements below:
Procedure groups referenced
- Transthoracic echocardiography codes (e.g., 93303–93308, 93350–93352): claims require diagnoses per Document ID #L33577/#A56781; Pediatric Cardiology specialty is excluded from this edit.
- Facet joint procedures (64490–64495, 64625, 64633–64636): claims require diagnoses per Document ID #L33577/#A57826.
- Corneal pachymetry (76514) and visual fields testing (92081–92083): claims require diagnoses per their respective LCD Document IDs (#L33630, #L33574) or will be denied for medical necessity.
- Nerve conduction studies and EMG procedure codes require appropriate diagnoses per Document ID #L35098 or will be denied for medical necessity.
Diagnosis linkage and medical necessity requirement
Claims for the listed laboratory and diagnostic procedures require an appropriate diagnosis for medical necessity:
Reimbursable diagnosis codes (Appendix)
Appendix — reimbursable diagnosis codes (examples):
Code Lists and Billing Limits
| 99050 | After-hours office services; must be billed with an E&M; not reimbursable when submitted with preventive visit codes. |
| 99051 | After-hours evening/weekend; must be billed with an E&M; considered inclusive to the E&M; not reimbursed separately for Commercial and Medicare (Medicaid/HARP reimbursed at Medicaid rate). |
| 99053 | Services between 10:00 pm and 8:00 am at 24-hour facility; must be billed with an E&M; considered inclusive to the E&M; not reimbursed separately. |
| 99056 | Services provided out of office at patient request; must be billed with an E&M; considered inclusive to the E&M; not reimbursed separately. |
| 99058 | Emergency basis in office disrupting scheduled services; must be billed with an E&M; considered inclusive to the E&M; not reimbursed separately. |
| 99060 | Emergency basis out of office disrupting scheduled services; must be billed with an E&M; considered inclusive to the E&M; not reimbursed separately. |
| 95165 | Supervision of preparation and provision of antigens for allergen immunotherapy; units/doses must be specified on claim; first year limited to 40 units per claim and 160 units per calendar year; subsequent years limited to 30 units per claim and 120 units per calendar year. |
| 95004 | Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including interpretation and report; number of tests must be specified; reimbursement limited to 80 units per calendar year. |
| 95024 | Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including interpretation and report; number of tests must be specified; reimbursement limited to 40 units per calendar year. |
| 95027 | Intracutaneous sequential/incremental tests for airborne allergens, immediate type reaction, including interpretation and report; number of tests must be specified; reimbursement limited to 40 units per calendar year. |
| 95028 | Intracutaneous tests with allergenic extracts, delayed type reaction, including reading; number of tests must be specified; reimbursement limited to 30 units per calendar year. |
| No codes listed |
| 99201-99499 | E&M visit codes (general rules on bundling, duplicates, inpatient rules). |
| 99381-99387, 99391-99397 | Preventive medicine E&M codes (preventive visits; certain same-day procedures not reimbursed separately). |
| G0102 | Manual rectal neoplasm screening — not reimbursed same day as 99202-99215 unless sole service. |
| 36415, 36416, 99000, 99001, Q0091, 92567, 94760, 94761 | Routine screening/lab procedures — generally not reimbursed separately same day as 99202-99215 unless sole service or external lab with modifier CG as specified. |
| 99406, 99407, G0376, G0375, S9453, S9075 | Smoking cessation counseling — not reimbursed unless member benefit indicates coverage. |
| 98960 | Diabetes education — reimbursed when billed alone; denied/bundled when billed with E&M office visit. |
| 98925-98929 | Osteopathic manipulation — not reimbursed unless contract exception. |
| 90460-90474, G0008-G0010 | Immunization administration — reimbursed only when billed with Z23 diagnosis. |
| 95115-95149 series | Allergy injections — reimbursable only with an E&M/Inpatient/ER visit billed with modifier 25. |
| 96900-96922 series | PUVA/UVA dermatologic treatments — reimbursable only with modifier 25 alongside E&M/Inpatient/ER visit. |
| 99201-99499 | Evaluation and Management codes (inpatient and other E&M ranges). |
| 99050-99060 | After-hours/E&M after-hour procedure codes; refer to After-Hours Payment Policy and contractual agreements for applicability. |
| 99291 | Critical care, first 30-74 minutes; reimbursed only if time ≥30 minutes per MVP rules (30-74 min = 99291 once). |
| 99292 | Critical care add-on unit(s) for additional time beyond initial period; additional 99292 units allowed per specified time blocks (75-104 min = 1 x 99292, 105-134 min = 2 x 99292, etc.). |
| arthroscopy/endoscopy families | Scope procedure code families (e.g., colonoscopy, cystoscopy, arthroscopy); when multiple within same family on same date, highest RVU procedure reimbursed and secondary procedures follow Medicare methodology reducing payment for additional procedures. |
| 99201-99499 | E&M CPT codes that audiologists may not bill. |
| 69209 | Cerumen removal code — audiologists may not bill; included in diagnostic test RVUs. |
| 69210 | Cerumen removal code — audiologists may not bill; included in diagnostic test RVUs. |
| G0268 | Physician code to bill when physician removes impacted cerumen same day as diagnostic test. |
| 92620 | Evaluation of central auditory function, with report; initial 60 minutes (timed code billed only if testing ≥51% of designated time). |
| 92621 | Evaluation of central auditory function, with report; each additional 15 minutes. |
| 92626 | Evaluation of auditory rehabilitation status; first hour. |
| 92627 | Evaluation of auditory rehabilitation status; each additional 15 minutes. |
| 92640 | Diagnostic analysis with programming of auditory brainstem implant, per hour. |
| 99441 | Telephone E/M service; 5-10 minutes of medical discussion (audio-only POS 99, Modifier V3). |
| 99442 | Telephone E/M service; 11-20 minutes of medical discussion (audio-only POS 99, Modifier V3). |
| 99443 | Telephone E/M service; 21-30 minutes of medical discussion (audio-only POS 99, Modifier V3). |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, per ml (not reimbursed separately). |
| Q9951 | Low osmolar contrast material, 400+ mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9965 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9966 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9959 | High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9960 | High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9961 | High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml (not reimbursed separately). |
| Applicable COVID-19 procedure codes as published in CPT by AMA or HCPCS by CMS; providers should follow CDC ICD-10-CM Official Coding Guidelines when selecting diagnosis codes. |
| Z02.0, Z02.1, Z02.4, Z02.5, Z02.79, Z02.89 | Examples of primary diagnosis codes that will be denied when submitted for COVID-19 testing (administrative/exam reasons). |
| Z02.9, Z56.89, Z56.9, Z03.818, Z76, Z01.89, Z13.9, Z71.89, Z71.82, R68.89, B34.9, E55.9, Z03.89, E03.9, Z56.5, Z00.00, K21.9, E11.9, R10.9, N23 | Additional example diagnosis codes considered inappropriate for COVID-19 testing reimbursement. |
| N39.0, R73.03, M54.5, E78.2, R07.89, K62.89, N89.8, M25.50, Z20.818, R42, Z09, K80.00, R07.9, N93.9, K29.00, I24.9, O24.419, E78.5, E16.2, J11.1, Z29.9, Z11.9 | Further examples of diagnosis codes listed as non-reimbursable for COVID-19 testing. |
| 97802 | Medical nutritional therapy; initial assessment and intervention, individual, face-to-face, each 15 minutes. |
| 97803 | Medical nutritional therapy; reassessment and intervention, individual, face-to-face, each 15 minutes. |
| 97804 | Medical nutritional therapy; group (2+ individuals), each 30 minutes. |
| G0270 | Medical nutritional therapy; reassessment and subsequent intervention(s) following second referral in same year, individual, each 15 minutes. |
| G0271 | Medical nutritional therapy; reassessment and subsequent intervention(s) following second referral in same year, group, each 30 minutes. |
| E09.* | Drug or chemical induced diabetes mellitus and associated complication subcodes (multiple specific codes listed). |
| E10.* | Type 1 diabetes mellitus and associated complication subcodes (multiple specific codes listed). |
| E11.* | Type 2 diabetes mellitus and associated complication subcodes (multiple specific codes listed). |
| E13.* | Other specified diabetes mellitus and associated complication subcodes (multiple specific codes listed). |
| E11.* | Type 2 diabetes mellitus codes with multiple complication subcodes listed (see policy excerpts). |
| E13.* | Other specified diabetes mellitus codes with multiple complication subcodes listed (see policy excerpts). |
| N18.* | Chronic kidney disease stages listed (N18.1, N18.2, N18.31, N18.32, N18.4, N18.5). |
| O24.* | Pregnancy-related diabetes codes (multiple O24 codes listed). |
| Z48.22 | Encounter for aftercare following kidney transplant. |
| E09.* | Drug or chemical induced diabetes mellitus and complications (multiple specific codes listed). |
| E10.* | Type 1 diabetes mellitus and complications (multiple specific codes listed). |
| E11.* | Type 2 diabetes mellitus and complications (multiple specific codes listed). |
| E13.* | Other specified diabetes mellitus and complications (multiple specific codes listed). |
| 93303-93308 | Transthoracic echocardiography for congenital cardiac anomalies and real-time transthoracic echocardiography groups referenced for diagnosis matching edits (93303-93308). |
| 93350-93352 | Transthoracic echocardiography during rest and cardiovascular stress testing (93350-93352). |
| 93308 | Echocardiography, transthoracic, real-time with image documentation (93308). |
| 93306-93308 | Real time transthoracic echocardiography code group (93306-93308) referenced for edits. |
| 51785 | Cystometrogram and related code listed in NCS/EMG group (included in group references). |
| 92265 | Ophthalmic diagnostic code referenced in NCS/EMG group (included in group references). |
| 95860-95874 | EMG and NCS procedure codes referenced for diagnosis matching edits. |
| 95885-95887 | Additional EMG/NCS related codes referenced. |
| 95905-95913 | NCS/EMG related procedure codes referenced. |
| 95933 | NCS/EMG group code referenced. |
| G0255 | NCS-related code referenced. |
| 95937 | Neuromuscular junction testing code referenced for diagnosis matching edits. |
| 76514 | Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness). |
| 64490-64495 | Facet joint injections and related diagnostic/therapeutic injection codes (cervical, thoracic, lumbar, sacral). |
| 64625 | Destruction by neurolytic agent, paravertebral facet joint nerve; Cervical, Thoracic, Lumbar, or Sacral. |
| 64633-64636 | Medial branch radiofrequency neurotomy and related codes. |
| 76514 | Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness). |
| 85652 | Erythrocyte sedimentation rate; automated. |
| 82746 | Assay of folic acid, serum. |
| 82607 | Cyanocobalamin (Vitamin B12) assay. |
| 83001 | Gonadotropin, follicle stimulating (FSH). |
| Z79899 | Other long term (current) drug therapy. |
| Z853 | Personal history of malignant neoplasm of breast. |
| E1165 | Type 2 diabetes mellitus with hyperglycemia. |
| B009 | Herpesviral infection, unspecified. |
| B0052 | Herpesviral keratitis. |
| Z01411 | Encounter for gynecological examination with abnormal findings. |
| J309 | Allergic rhinitis, unspecified. |
| L500 | Allergic urticaria. |
| T7800XA | Anaphylactic reaction due to unspecified food, initial encounter. |
| T63481A | Toxic effect of venom of wasps, accidental (unintentional), subsequent encounter. |
| T6391XA | Toxic effect of venom of other arthropod, accidental (unintentional), initial encounter. |
| T6391XS | Toxic effect of contact with unspecified venomous animal, accidental (unintentional), sequela. |
| T65811A | Toxic effect of latex, accidental (unintentional), initial encounter. |
| T7800XA | Anaphylactic reaction due to unspecified food, initial encounter. |
| T7801XA | Anaphylactic reaction due to peanuts, initial encounter. |
| T7801XD | Anaphylactic reaction due to peanuts, subsequent encounter. |
| Z0182 | Encounter for allergy testing. |
| Z91010 | Allergy to peanuts. |
| Z91030 | Bee allergy status. |
| C029 | Malignant neoplasm of tongue, unspecified. |
| C220 | Liver cell carcinoma. |
| C3411 | Malignant neoplasm of upper lobe, right bronchus, or lung. |
| C9000 | Multiple myeloma not having achieved remission. |
| C9110 | Chronic lymphocytic leukemia of B-cell type not having achieved remission. |
| D550 | Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency. |
| D630 | Anemia in neoplastic disease. |
| D689 | Sarcoidosis, unspecified. |
| D824 | Hyperimmunoglobulin E [IgE] syndrome. |
| D891 | Cryoglobulinemia. |
Provider Responsibilities, Prior Authorization, and Documentation
Verify eligibility and check UM guides before providing services
Providers must check member eligibility, refer to the Member Benefits Display, review MVP's Utilization Management Guides to determine if prior authorization is required, and consult the Benefit Interpretation Manual; resources are accessible by signing into your provider account at mvphealthcare.com.
Confirm member eligibility and UM requirements for allergy testing
For allergy testing, providers must confirm Member eligibility and refer to the Member Benefits Display; they must also review MVP's Utilization Management Guides to determine if prior authorization is required. Access these resources by signing into your provider account at mvphealthcare.com.
Check eligibility and UM guides for prior authorization/notification
Providers must check member eligibility, refer to the Member Benefits Display, and review MVP's Utilization Management Guides to determine if prior authorization or notification is required; resources are available via the provider account at mvphealthcare.com.
Verify eligibility and required authorizations using MVP resources
Providers must check member eligibility, consult the Member Benefits Display, review MVP's Utilization Management Guides for prior authorization requirements, and consult the Benefit Interpretation Manual for clinical guidance; access these resources by signing into your account at mvphealthcare.com.
Use After‑Hours Payment Policy and contract to determine applicability
Refer to the MVP After-Hours Payment Policy for guidance on billing and reimbursement of after‑hours E/M codes (99051–99060) and consult your contractual agreement to determine applicability of the rule.
Verify eligibility and prior authorization requirements via MVP resources
Providers must check Member eligibility, consult the Member Benefits Display, and review MVP's Utilization Management Guides and Benefit Interpretation Manual to determine prior authorization requirements before providing services; these resources are available via the provider portal.
Obtain authorization for In‑Office Only codes to be eligible for split billing reimbursement
Procedure codes on the MVP In‑Office Only list will not be reimbursed under a split billing arrangement unless authorization is obtained; if authorized, reimbursement may be allowed for Medicare and Medicaid products.
Confirm eligibility and authorization requirements before delivering services
Providers must check member eligibility, refer to the Member Benefits Display, and review MVP's Utilization Management Guides and Benefit Interpretation Manual to determine if prior authorization is required prior to rendering services; access via provider account.
Obtain required authorizations to avoid administrative denials
Authorizations are required for select services identified in MVP's Utilization Management Guides; when authorization is required and not obtained, all technical, professional, global and/or facility claims associated with those services will be administratively denied (applies to outpatient surgical services and the Radiology code set). Providers must check member eligibility and the UM guides for authorization requirements.
Verify eligibility and prior authorization requirements prior to service
Providers must check member eligibility and review MVP's Utilization Management Guides and Benefit Interpretation Manual to determine whether prior authorization is required before performing services; resources accessed by signing into the provider account at mvphealthcare.com.
Confirm eligibility and authorization; policies do not guarantee payment
Providers must check member eligibility, refer to the Member Benefits Display, and review MVP's Utilization Management Guides and Benefit Interpretation Manual to determine if prior authorization is required; policies are not guarantees of payment.
ICD‑10 diagnosis listings for Nutritional Counseling (no authorization rules here)
This section provides ICD‑10 diagnosis code listings used in the Nutritional Counseling section; no prior authorization, denial risk, documentation, billing rule, or step therapy actions are specified in this excerpt.
Billing restriction for G0108/G0109 — diagnosis limitation for Medicare MSA plans
G0108 and G0109 are considered reimbursable for Diabetic Management; reimbursement for these codes is limited to specified diagnoses for Medicare MSA plans (all other plans reimburse ICD‑10 in range E08–E09).
Refer to ICD‑10 mappings for drug/chemical‑induced diabetes diagnoses
Listings of ICD‑10 codes for drug/chemical‑induced diabetes mellitus are provided for diabetic management coding and reference in the policy.
Verify eligibility and submit correct diagnosis per LCD/NCD to avoid denial
Providers must check member eligibility, consult the Member Benefits Display, and review MVP's Utilization Management Guides to determine if prior authorization is required; MVP requires the correct diagnosis be submitted with the claim per Medicare LCD/NCD or the claim will be denied for medical necessity.
Submit correct diagnosis for corneal pachymetry (76514) per LCD
MVP requires the correct diagnosis be submitted with claims for corneal pachymetry (76514) in accordance with the applicable Medicare Local Coverage Determination; failure to submit the correct diagnosis will result in denial for medical necessity.
Submit correct diagnosis for visual field testing (92081–92083) per LCD
MVP requires the correct diagnosis be submitted with claims for visual field testing (92081–92083) in accordance with the Medicare Local Coverage Determination; failure to submit the correct diagnosis will result in denial for medical necessity.
Use appropriate diagnoses for Herpes Simplex antibody tests (86695/86696) or claim will deny
MVP requires the correct diagnosis be submitted with claims for Herpes Simplex antibody testing (86695, 86696) in accordance with USPSTF and AAFP or clinical guidance; claims without an appropriate diagnosis will be denied for medical necessity. See the Appendix for appropriate diagnosis codes.
Submit appropriate diagnosis for Vitamin D tests (82306/82652) per LCD
MVP requires the correct diagnosis be submitted with claims for Vitamin D testing (82306, 82652) in accordance with the Medicare LCD; claims submitted without the appropriate diagnosis will be denied for medical necessity.
Provide appropriate diagnosis for ESR automated test (85652) or claim will be denied
MVP requires the correct diagnosis be submitted with claims for the erythrocyte sedimentation rate automated test (85652) in accordance with ASCP guidance; claims lacking the appropriate diagnosis will be denied for medical necessity.
Refer to AAAAI guidance and Appendix for appropriate diagnoses for Allergen/IgE tests
For allergen and IgE testing (82785, 86003, 86008), providers should refer to guidance from the American Academy of Allergy, Asthma & Immunology and the policy Appendix to identify appropriate diagnoses to submit with claims.
Submit correct diagnosis for folic acid assay (82746) per clinical guidance
MVP requires the correct diagnosis be submitted with claims for folic acid assay (82746) in accordance with clinical guidance; submit appropriate diagnoses from the Appendix to avoid denial.
Provide correct diagnosis for Vitamin B12 testing (82607) per LCD
MVP requires the correct diagnosis be submitted with claims for Vitamin B12 testing (82607) in accordance with the Medicare Local Coverage Determination; failure to submit the appropriate diagnosis will result in denial for medical necessity.
Submit appropriate diagnosis for FSH testing (83001) per ASRM guidance
MVP requires the correct diagnosis be submitted with claims for follicle stimulating hormone testing (83001) in accordance with American Society for Reproductive Medicine guidance; claims without an appropriate diagnosis will be denied for medical necessity. Refer to the Appendix for appropriate diagnosis codes.
Ensure correct diagnoses for TSH/thyroxine tests (84436/84439/84479) per LCD
MVP requires the correct diagnosis be submitted with claims for thyroid function tests (84436, 84439, 84479) according to Medicare LCDs; claims submitted without the appropriate diagnosis will be denied for medical necessity.
Use listed ICD‑10 diagnoses associated with FSH therapy when appropriate
The policy lists ICD‑10 diagnosis codes and descriptions associated with Follicle Stimulating Hormone therapy (examples include Z79899, Z853, E11.65, E11.9); consult these codes when submitting claims related to FSH testing or therapy.
Use Appendix ICD‑10 codes for Herpes Simplex Virus claims
The Appendix lists ICD‑10 diagnosis codes associated with Herpes Simplex Virus conditions and encounters (examples shown in the policy); use these listed diagnoses when submitting claims for related services.
Refer to listed ICD‑10 codes for Gammaglobulin IgE indications
The policy lists ICD‑10 diagnosis codes associated with Gammaglobulin IgE indications (examples include allergic and respiratory codes J30‑J309 and L50‑L509); refer to these codes in the Appendix when submitting claims for 82785/86003/86008.
Use Appendix ICD‑10 codes for Gammaglobulin IgE and allergy testing
The policy provides additional ICD‑10 codes describing toxic effects, anaphylactic reactions, allergies, and encounters for allergy testing (e.g., T7800XA, Z0182); consult these codes in the Appendix when billing related services.
Consult Appendix ICD‑10 list when submitting ESR (85652) claims
An extensive list of ICD‑10 codes associated with indications for erythrocyte sedimentation rate testing is provided in the policy Appendix; consult the Appendix to select an appropriate diagnosis when submitting claims for ESR (85652).
Definitions and Key Terms
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.